O
Onkabetse Julia Molefe-Baikai
Researcher at University of Botswana
Publications - 10
Citations - 147
Onkabetse Julia Molefe-Baikai is an academic researcher from University of Botswana. The author has contributed to research in topics: Atrial fibrillation & Population. The author has an hindex of 5, co-authored 8 publications receiving 56 citations.
Papers
More filters
Journal ArticleDOI
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
Ganesan Karthikeyan,Stuart J. Connolly,Mpiko Ntsekhe,Alexander P. Benz,Sumathy Rangarajan,Gayle Lewis,Yan Yun,Sanjib Sharma,Fathi A. Maklady,Alaa Eldin Elghamrawy,Khawar Kazmi,Tantchou T J Cabral,Hu Dayi,Ma Changsheng,Bernard Gitura,Alvaro Avezum,Liesl Zühlke,Peter Lwabi,Abraham Haileamlak,Okechukwu S Ogah,Pilly Chillo,Maria Paniagua,Ahmed Elsayed,Antonio L. Dans,Lillian Gondwe-Chunda,Onkabetse Julia Molefe-Baikai,Jesus A Gonzalez-Hermosillo,James Hakim,Albertino Damasceno,Emmanuel R Kamanzi,John Musuku,Kairat Davletov,Katherine Connolly,Bongani M. Mayosi,Salim Yusuf,Invictus Investigators +35 more
TL;DR: INVICTUS is the largest program of clinical research focused on a neglected cardiovascular disease and will provide new information on the clinical course of patients with RHD, and approaches to anticoagulation in those with concomitant AF.
letters-and-commentsDOI
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
Stuart J. Connolly,Ganesan Karthikeyan,Mpiko Ntsekhe,Abraham Haileamlak,Armed El Sayed,A. El Ghamrawy,Albertino Damasceno,Alvaro Avezum,Antonio L. Dans,Bernard Gitura,Dayi Hu,Emmanuel R Kamanzi,Fathi A. Maklady,Golden T Fana,J. Gonzalez-Hermosillo,John Musuku,Khawar Kazmi,Liesl Zühlke,Lillian Gondwe,Changsheng Ma,M.J Paniagua,Okechukwu S Ogah,Onkabetse Julia Molefe-Baikai,Peter Lwabi,Pilly Chillo,Sanjib Sharma,Tantchou Tchoumi Jacques Cabral,Wadea Tarhuni,Alexander P Benz,Martin van Eikels,Amy Krol,Divya Pattath,Kumar Balasubramanian,Sumathy Rangarajan,Chinthanie Ramasundarahettige,Bongani M. Mayosi,Salim Yusuf +36 more
TL;DR: Among patients with rheumatic heart disease-associated atrial fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of cardiovascular events or death than rivaroxaban therapy, without a higher rate of bleeding.
Journal ArticleDOI
Benefits and Risks of Statin Therapy in the HIV-Infected Population
TL;DR: Pitavastatin is the statin of choice for the ongoing largest trial (6500 participants) to test the benefits of statin therapy among HIV-infected adults and is underutilized in the prevention of CVD in HIV- Infected populations based on criteria in established cholesterol guidelines.
Journal ArticleDOI
Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study.
Julius Chacha Mwita,Joel M. Francis,Bernard Omech,Elizabeth Botsile,Aderonke Oyewo,Matshidiso Mokgwathi,Onkabetse Julia Molefe-Baikai,Brian Godman,Jose-Gaby Tshikuka +8 more
TL;DR: Patients with T2DM in Gaborone, Botswana, presented with suboptimal control of recommended glycaemic, hypertension and LDL-C targets, calling for urgent individual and health systems interventions to address key determinants of the recommended therapeutic targets among patients with diabetes.
Journal ArticleDOI
The prevalence of microalbuminuria and associated factors among patients with type 2 diabetes mellitus in Botswana
Onkabetse Julia Molefe-Baikai,Mooketsi Molefi,Francesca Cainelli,Godfrey Mutashambara Rwegerera +3 more
TL;DR: High prevalence of Microalbuminuria raises an urgent need for changes in the management of patients with type 2 DM in Botswana, with emphasis on prevention and reduction of MA to avoid development of overt diabetic nephropathy and ensuing cardiovascular morbidity and mortality.